Linear Cyclodextrin Polymer Prodrugs as Novel Therapeutics for Niemann-Pick Type C1 Disorder

Niemann-Pick Type C1 disorder (NPC) is a rare lysosomal storage disease characterized by the accumulation of cholesterol in lysosomes. NPC has no FDA approved treatments yet, however 2-hydroxypropyl-β-cyclodextrin (HPβCD) has shown efficacy for treating the disease in both mouse and feline NPC model...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Aditya, Caporali, Paola, Dolas, Atul, Johny, Soniya, Goyal, Sandeep, Dragotto, Jessica, Macone, Alberto, Jayaraman, Ramesh, Fiorenza, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015065/
https://www.ncbi.nlm.nih.gov/pubmed/29934581
http://dx.doi.org/10.1038/s41598-018-27926-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015065/
https://www.ncbi.nlm.nih.gov/pubmed/29934581
http://dx.doi.org/10.1038/s41598-018-27926-9

Ejemplares similares